Product NDC: | 66685-1011 |
Proprietary Name: | Amoxicillin and Clavulanate Potassium |
Non Proprietary Name: | amoxicillin and clavulanate potassium |
Active Ingredient(s): | 200; 28.5 mg/5mL; mg/5mL & nbsp; amoxicillin and clavulanate potassium |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66685-1011 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065098 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040813 |
Package NDC: | 66685-1011-1 |
Package Description: | 75 mL in 1 BOTTLE (66685-1011-1) |
NDC Code | 66685-1011-1 |
Proprietary Name | Amoxicillin and Clavulanate Potassium |
Package Description | 75 mL in 1 BOTTLE (66685-1011-1) |
Product NDC | 66685-1011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | amoxicillin and clavulanate potassium |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20040813 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | AMOXICILLIN; CLAVULANATE POTASSIUM |
Strength Number | 200; 28.5 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |